Chiral Self Assembled Monolayers as Resolving Auxiliaries in the Crystallization of Valine
Chiral drugs are a subgroup of drug substances that contain one or more chiral centers. For reasons of safety and efficacy, the pure enantiomer is usually preferred over the racemate in many marketed dosage forms. Thus, resolution ofracemic mixtures is an active area of research. In this work, chira...
Gespeichert in:
Veröffentlicht in: | Journal of pharmaceutical sciences 2010-09, Vol.99 (9), p.3931-3940 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3940 |
---|---|
container_issue | 9 |
container_start_page | 3931 |
container_title | Journal of pharmaceutical sciences |
container_volume | 99 |
creator | Singh, Aniruddh Myerson, Allan S. |
description | Chiral drugs are a subgroup of drug substances that contain one or more chiral centers. For reasons of safety and efficacy, the pure enantiomer is usually preferred over the racemate in many marketed dosage forms. Thus, resolution ofracemic mixtures is an active area of research. In this work, chiral self assembled monolayers (SAMs) on gold were employed as resolving auxiliaries in the crystallization of the amino acid valine. Results showed the ability to obtain one enantiomer in excess on the crystals grown on the chiral SAMs when starting with racemic solutions. The enantiomer obtained in excess was the one having opposite chirality to the monolayer being used. In addition, it was possible to obtain crystals of the pure enantiomer when starting with a solution having an enantiomeric excess value of 50%. Control experiments carried out without chiral SAMs showed that at equilibrium, mixtures of the pure enantiomer and racemic compound were obtained under these conditions. The enantiomer obtained on the chiral SAMs was the one that was initially present in excess regardless of the chirality of the monolayer being used. |
doi_str_mv | 10.1002/jps.22237 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_748932954</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354915324965</els_id><sourcerecordid>748932954</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3867-96ef61c39859bfade79f464f84d03fe93c1d60880dae04591a06a7b03beb57273</originalsourceid><addsrcrecordid>eNp10MFu1DAQBmALgehSOPACyBeEOKR17DiOj6tVaanaglgoEhfLccbUxRsvnmzp8vQEsi0XmIsP882M_BPyvGQHJWP88HqNB5xzoR6QWSk5K2pWqodkNvZ4IWSl98gTxGvGWM2kfEz2OJNCSMln5MviKmQb6RKip3NEWLUROnqe-hTtFjJSi_QDYIo3of9K55vbEIPNAZCGng5XQBd5i4ONMfy0Q0g9TZ5e2hh6eEoeeRsRnu3effLpzdHHxUlx9u747WJ-VjjR1KrQNfi6dEI3UrfedqC0r-rKN1XHhActXNnVrGlYZ4FVUpeW1Va1TLTQSsWV2Cevpr3rnL5vAAezCuggRttD2qBRVaMF17Ia5etJupwQM3izzmFl89aUzPxO0oxJmj9JjvbFbuumXUF3L--iG8HLHbDobPTZ9i7gXyd42Yw1usPJ_QgRtv-_aE7fL-9OF9NEwAFu7yds_mZqJZQ0ny-OzYla6svTi8qcj15MHsaUbwJkgy5A76ALGdxguhT-8cFfB0mq_w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>748932954</pqid></control><display><type>article</type><title>Chiral Self Assembled Monolayers as Resolving Auxiliaries in the Crystallization of Valine</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Singh, Aniruddh ; Myerson, Allan S.</creator><creatorcontrib>Singh, Aniruddh ; Myerson, Allan S.</creatorcontrib><description>Chiral drugs are a subgroup of drug substances that contain one or more chiral centers. For reasons of safety and efficacy, the pure enantiomer is usually preferred over the racemate in many marketed dosage forms. Thus, resolution ofracemic mixtures is an active area of research. In this work, chiral self assembled monolayers (SAMs) on gold were employed as resolving auxiliaries in the crystallization of the amino acid valine. Results showed the ability to obtain one enantiomer in excess on the crystals grown on the chiral SAMs when starting with racemic solutions. The enantiomer obtained in excess was the one having opposite chirality to the monolayer being used. In addition, it was possible to obtain crystals of the pure enantiomer when starting with a solution having an enantiomeric excess value of 50%. Control experiments carried out without chiral SAMs showed that at equilibrium, mixtures of the pure enantiomer and racemic compound were obtained under these conditions. The enantiomer obtained on the chiral SAMs was the one that was initially present in excess regardless of the chirality of the monolayer being used.</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1002/jps.22237</identifier><identifier>PMID: 20533552</identifier><identifier>CODEN: JPMSAE</identifier><language>eng</language><publisher>Hoboken: Elsevier Inc</publisher><subject>Acetylcysteine - chemistry ; Biological and medical sciences ; chirality ; crystal engineering ; crystal structure ; crystallization ; Crystallization - methods ; Cysteine - chemistry ; General pharmacology ; Glutathione - chemistry ; Gold - chemistry ; Medical sciences ; Penicillamine - chemistry ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; separation science ; Solubility ; Stereoisomerism ; Valine - chemistry</subject><ispartof>Journal of pharmaceutical sciences, 2010-09, Vol.99 (9), p.3931-3940</ispartof><rights>2010 Wiley-Liss, Inc.</rights><rights>Copyright © 2010 Wiley‐Liss, Inc.</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3867-96ef61c39859bfade79f464f84d03fe93c1d60880dae04591a06a7b03beb57273</citedby><cites>FETCH-LOGICAL-c3867-96ef61c39859bfade79f464f84d03fe93c1d60880dae04591a06a7b03beb57273</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjps.22237$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjps.22237$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23218888$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20533552$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Singh, Aniruddh</creatorcontrib><creatorcontrib>Myerson, Allan S.</creatorcontrib><title>Chiral Self Assembled Monolayers as Resolving Auxiliaries in the Crystallization of Valine</title><title>Journal of pharmaceutical sciences</title><addtitle>J. Pharm. Sci</addtitle><description>Chiral drugs are a subgroup of drug substances that contain one or more chiral centers. For reasons of safety and efficacy, the pure enantiomer is usually preferred over the racemate in many marketed dosage forms. Thus, resolution ofracemic mixtures is an active area of research. In this work, chiral self assembled monolayers (SAMs) on gold were employed as resolving auxiliaries in the crystallization of the amino acid valine. Results showed the ability to obtain one enantiomer in excess on the crystals grown on the chiral SAMs when starting with racemic solutions. The enantiomer obtained in excess was the one having opposite chirality to the monolayer being used. In addition, it was possible to obtain crystals of the pure enantiomer when starting with a solution having an enantiomeric excess value of 50%. Control experiments carried out without chiral SAMs showed that at equilibrium, mixtures of the pure enantiomer and racemic compound were obtained under these conditions. The enantiomer obtained on the chiral SAMs was the one that was initially present in excess regardless of the chirality of the monolayer being used.</description><subject>Acetylcysteine - chemistry</subject><subject>Biological and medical sciences</subject><subject>chirality</subject><subject>crystal engineering</subject><subject>crystal structure</subject><subject>crystallization</subject><subject>Crystallization - methods</subject><subject>Cysteine - chemistry</subject><subject>General pharmacology</subject><subject>Glutathione - chemistry</subject><subject>Gold - chemistry</subject><subject>Medical sciences</subject><subject>Penicillamine - chemistry</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>separation science</subject><subject>Solubility</subject><subject>Stereoisomerism</subject><subject>Valine - chemistry</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10MFu1DAQBmALgehSOPACyBeEOKR17DiOj6tVaanaglgoEhfLccbUxRsvnmzp8vQEsi0XmIsP882M_BPyvGQHJWP88HqNB5xzoR6QWSk5K2pWqodkNvZ4IWSl98gTxGvGWM2kfEz2OJNCSMln5MviKmQb6RKip3NEWLUROnqe-hTtFjJSi_QDYIo3of9K55vbEIPNAZCGng5XQBd5i4ONMfy0Q0g9TZ5e2hh6eEoeeRsRnu3effLpzdHHxUlx9u747WJ-VjjR1KrQNfi6dEI3UrfedqC0r-rKN1XHhActXNnVrGlYZ4FVUpeW1Va1TLTQSsWV2Cevpr3rnL5vAAezCuggRttD2qBRVaMF17Ia5etJupwQM3izzmFl89aUzPxO0oxJmj9JjvbFbuumXUF3L--iG8HLHbDobPTZ9i7gXyd42Yw1usPJ_QgRtv-_aE7fL-9OF9NEwAFu7yds_mZqJZQ0ny-OzYla6svTi8qcj15MHsaUbwJkgy5A76ALGdxguhT-8cFfB0mq_w</recordid><startdate>201009</startdate><enddate>201009</enddate><creator>Singh, Aniruddh</creator><creator>Myerson, Allan S.</creator><general>Elsevier Inc</general><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><general>American Pharmaceutical Association</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201009</creationdate><title>Chiral Self Assembled Monolayers as Resolving Auxiliaries in the Crystallization of Valine</title><author>Singh, Aniruddh ; Myerson, Allan S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3867-96ef61c39859bfade79f464f84d03fe93c1d60880dae04591a06a7b03beb57273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Acetylcysteine - chemistry</topic><topic>Biological and medical sciences</topic><topic>chirality</topic><topic>crystal engineering</topic><topic>crystal structure</topic><topic>crystallization</topic><topic>Crystallization - methods</topic><topic>Cysteine - chemistry</topic><topic>General pharmacology</topic><topic>Glutathione - chemistry</topic><topic>Gold - chemistry</topic><topic>Medical sciences</topic><topic>Penicillamine - chemistry</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>separation science</topic><topic>Solubility</topic><topic>Stereoisomerism</topic><topic>Valine - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Singh, Aniruddh</creatorcontrib><creatorcontrib>Myerson, Allan S.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Singh, Aniruddh</au><au>Myerson, Allan S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chiral Self Assembled Monolayers as Resolving Auxiliaries in the Crystallization of Valine</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J. Pharm. Sci</addtitle><date>2010-09</date><risdate>2010</risdate><volume>99</volume><issue>9</issue><spage>3931</spage><epage>3940</epage><pages>3931-3940</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><coden>JPMSAE</coden><abstract>Chiral drugs are a subgroup of drug substances that contain one or more chiral centers. For reasons of safety and efficacy, the pure enantiomer is usually preferred over the racemate in many marketed dosage forms. Thus, resolution ofracemic mixtures is an active area of research. In this work, chiral self assembled monolayers (SAMs) on gold were employed as resolving auxiliaries in the crystallization of the amino acid valine. Results showed the ability to obtain one enantiomer in excess on the crystals grown on the chiral SAMs when starting with racemic solutions. The enantiomer obtained in excess was the one having opposite chirality to the monolayer being used. In addition, it was possible to obtain crystals of the pure enantiomer when starting with a solution having an enantiomeric excess value of 50%. Control experiments carried out without chiral SAMs showed that at equilibrium, mixtures of the pure enantiomer and racemic compound were obtained under these conditions. The enantiomer obtained on the chiral SAMs was the one that was initially present in excess regardless of the chirality of the monolayer being used.</abstract><cop>Hoboken</cop><pub>Elsevier Inc</pub><pmid>20533552</pmid><doi>10.1002/jps.22237</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3549 |
ispartof | Journal of pharmaceutical sciences, 2010-09, Vol.99 (9), p.3931-3940 |
issn | 0022-3549 1520-6017 |
language | eng |
recordid | cdi_proquest_miscellaneous_748932954 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection |
subjects | Acetylcysteine - chemistry Biological and medical sciences chirality crystal engineering crystal structure crystallization Crystallization - methods Cysteine - chemistry General pharmacology Glutathione - chemistry Gold - chemistry Medical sciences Penicillamine - chemistry Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments separation science Solubility Stereoisomerism Valine - chemistry |
title | Chiral Self Assembled Monolayers as Resolving Auxiliaries in the Crystallization of Valine |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T09%3A37%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chiral%20Self%20Assembled%20Monolayers%20as%20Resolving%20Auxiliaries%20in%20the%20Crystallization%20of%20Valine&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Singh,%20Aniruddh&rft.date=2010-09&rft.volume=99&rft.issue=9&rft.spage=3931&rft.epage=3940&rft.pages=3931-3940&rft.issn=0022-3549&rft.eissn=1520-6017&rft.coden=JPMSAE&rft_id=info:doi/10.1002/jps.22237&rft_dat=%3Cproquest_cross%3E748932954%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=748932954&rft_id=info:pmid/20533552&rft_els_id=S0022354915324965&rfr_iscdi=true |